Meera

Each 5 mL Syrup contains: Butamirate Citrate 7.5 mg.

Meera (Butamirate Citrate) acts directly on the brain's cough center to suppress cough. Meera (Butamirate Citrate) is safe and non-sedating which is neither chemically nor pharmacologically related to opium alkaloids. Meera (Butamirate Citrate) is rapidly & completely absorbed after oral administration. Maximum concentration is reached within 9 hours with sustained release tablet. Plasma elimination half-life of Meera (Butamirate Citrate) is about 13 hours.
Pharmacology: Butamirate Citrate belongs to the anti-cough medicines of central action. It exerts expectorant, moderate bronchodilating and anti-inflammatory action. Butamirate Citrate also increases the spirometry indexes and blood oxygenation. It is safe and non-sedating which is neither chemically nor pharmacologically related to opium alkaloids. The active metabolites of Butamirate Citrate have also antitussive action.

Meera (Butamirate Citrate) is used to relieve dry (non-productive) cough. Dry cough may be caused by a recent viral infection. Meera (Butamirate Citrate) is also used for pre & post-operative cough sedation in patients who will undergo surgical procedures and bronchoscopy. It can be used in acute cough of any etiology, whooping cough and cough due to acute lower respiratory tract infections (tracheitis, laryngitis, bronchitis) etc.

Meera Syrup.
Children (3-6 yrs): 5 mL 3 times daily.
Children (6-12 yrs): 10 mL 3 times daily.
Adolescent: 15 mL 3 times daily.
Adults: 15 mL 4 times daily.

Accidental overdose with Meera (Butamirate Citrate) can cause the following symptoms: drowsiness, nausea, vomiting, diarrhoea, loss of balance & hypotension. Standard emergency procedures should be followed: activated charcoal, saline laxatives & standard cardio-respiratory resuscitation.

Hypersensitivity to the active ingredient.

Meera (Butamirate Citrate) should not be used during the 1st trimester of pregnancy. It can be used if indicated by a physician but with caution. As a general rule, for safety reasons, in the absence of data on elimination of the active substance in breast milk, the benefits of Meera (Butamirate Citrate) administration during breast feeding should be carefully weighed against the risks.

Tolerance of Meera (Butamirate Citrate) is good.
Adverse reactions such as rash, nausea, diarrhoea & vertigo have been observed in a few rare cases, resolving after dose reduction or treatment withdrawal.

Keep away from light & moisture. Store below 30°C.

Cough & Cold Preparations

R05DB13 - butamirate ; Belongs to the class of other cough suppressants.

Non-Rx